More about

Gout

News
February 21, 2020
4 min read
Save

Wartime 'innovation' spurred revolution in rheumatology, surfing technology

Wartime 'innovation' spurred revolution in rheumatology, surfing technology

MAUI, Hawaii — Although traditionally marked by scant changes in treatment and diagnosis from its prehistoric roots, the field of rheumatology experienced a windfall of “disruptive innovation” following World War II — an unlikely catalyst that also revolutionized surfing technology, according to a unique “Hawaiian TED Talk” presented at the 2020 Rheumatology Winter Clinical Symposium.

News
February 20, 2020
3 min read
Save

Allopurinol, febuxostat carry similar risks for hypersensitivity reactions

Allopurinol, febuxostat carry similar risks for hypersensitivity reactions

Both allopurinol and febuxostat carry similar, significant increased risks for hypersensitivity reactions compared with colchicine, according to data published in Annals of the Rheumatic Diseases.

News
January 16, 2020
2 min read
Save

Mental distress highly prevalent among adults with arthritis in Appalachia, southern US

Mental distress highly prevalent among adults with arthritis in Appalachia, southern US

Frequent mental distress is commonly reported among adults with arthritis across all 50 states and Washington, D.C., with the highest prevalence reported in the Appalachian region and southern states, according to data published in Morbidity and Mortality Weekly Report.

News
January 16, 2020
12 min read
Save

New use for an old drug: The potential of colchicine in CVD

New use for an old drug: The potential of colchicine in CVD

Secondary prevention of CVD with colchicine is a major focus for the cardiology community, especially after recent presentations of the COLCOT and COLCHICINE-PCI trials at the American Heart Association Scientific Sessions in November.

News
January 13, 2020
2 min read
Save

SGLT2 inhibitors may lower gout risk

SGLT2 inhibitors may lower gout risk

Among patients with type 2 diabetes, using SGLT2 inhibitors may lower the risk for gout compared with other antidiabetic medications, according to study findings published in the Annals of Internal Medicine.

News
December 16, 2019
2 min read
Save

Intersectional inequalities persist for OA, RA, gout diagnosis, not SpA

Intersectional inequalities persist for OA, RA, gout diagnosis, not SpA

Although there are considerable intersectional inequalities among various age, gender and socioeconomic groups in the likelihood of diagnosis for osteoarthritis, gout and rheumatoid arthritis, no such inequalities were found for spondyloarthritis diagnosis, according to findings published in Arthritis Care & Research.

News
December 16, 2019
13 min read
Save

Failure of Management: Treatment Gaps at the Root of Dismal Gout Care

Failure of Management: Treatment Gaps at the Root of Dismal Gout Care

Experts might use words like “suboptimal” or “insufficient” to describe gout management in the United States. To be fair, many gout specialists and rheumatologists use those exact words. But they also say that gout management in the U.S. is “crummy” or outright “sucks.” They say these things not behind closed doors or at dinner meetings, but from the dais of national and international rheumatology conferences. This suggests that gout management is beyond problematic.

News
December 16, 2019
1 min read
Save

Ace the Case: A 78-Year-Old Man With Acute Onset of Right Ankle Pain and Swelling

Learning Objective:

News
December 14, 2019
2 min read
Save

Top news from AHA: ISCHEMIA, dapagliflozin for HF, gout drug post-MI

Top news from AHA: ISCHEMIA, dapagliflozin for HF, gout drug post-MI

Healio and Cardiology Today reported live from the American Heart Association Scientific Sessions in Philadelphia, bringing readers the latest research and breaking news in cardiology.

News
December 12, 2019
2 min read
Save

Renal failure reported more often with allopurinol, febuxostat

Renal failure reported more often with allopurinol, febuxostat

Reports of acute renal failure occur 5.7 times more frequently among patients treated with febuxostat, and 3.3 times more often with allopurinol, compared with other drugs, according to data published in Arthritis Research & Therapy.

View more